Ligand Pharmaceuticals to Acquire XOMA Royalty Company for $740 Million
Ligand Pharmaceuticals announced it will acquire biotech royalty investment firm XOMA Royalty Company for approximately …
🏷️ Royalty Investment
1 articles about 'Royalty Investment'
1